Pfizer Inc (MIL:1PFE)
€ 25 -0.395 (-1.56%) Market Cap: 140.28 Bil Enterprise Value: 192.77 Bil PE Ratio: 36.11 PB Ratio: 1.64 GF Score: 63/100

Pfizer Inc at Cowen Healthcare Conference (Virtual) Transcript

Mar 01, 2021 / 08:20PM GMT
Stephen Michael Scala
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst

Good afternoon, and welcome once again to Cowen's 41st Annual Healthcare Conference. We're very pleased to have with us, again, this year, Pfizer. Representing the company, Angela Hwang, Group President of Pfizer Biopharmaceuticals Group.

We, at Cowen, are recommending Pfizer stock. And we like it because of the improved innovation in the lab, which is bringing forth many value-added products to the market. And of course, it's Angela's job to make them commercially successful. So this is a great opportunity to spend some time with a key person at the company.

Chuck Triano needs to read an important statement. So I'll give him a chance to do that, and then we'll head into the questions.

Charles E. Triano
Pfizer Inc. - SVP of IR

Great. Thanks, Steve.

Just a quick reminder on forward-looking statement. Of course, Angela will be making some forward-looking commentary and statements here. And as you're all familiar, actual results could

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot